Other Species / Isoforms
  HIR (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K38
YFANLSNKSQRYMAD
0 1
HIR (human) YFANLSNKSQRYMAD K38
HIR (mouse) YFANLSNkSQRYMAD K38-ub
HIR (rat) YFANLSNKSQRYMAD K38
T53-p
IFTTCVDtRWRYMLM
Upstream
Downstream
1 0
Effects on Modified Protein
  • activity, inhibited
Putative in vivo kinases:
  • PKCA (human)
HIR (human) IFTTCVDtRWRYMLM T53-p
HIR (mouse) IFTTCVDTRWRYMLM T53
HIR (rat) IFTTCVDTRWRYMLM T53
K225
HVRAQLIKPYMTQEG
0 1
HIR (human) HVRAQLIKPYMTQEG K225
HIR (mouse) HVRAQLIkPYMTQEG K224-ub
HIR (rat) HVRAQLIKPYMTQEG K225
Y234-p
YMTQEGEyLPLDQRD
Upstream
Downstream
1 0
Effects on Modified Protein
  • activity, induced
Putative in vivo kinases:
  • EGFR (human)
Treatment
  • AG1295
  • AG556
  • EGF
  • vanadate
HIR (human) YMTQEGEyLPLDQRD Y234-p
HIR (mouse) YMTQEGEYLPLDQRD Y233
HIR (rat) YMTQEGEYLPLDQRD Y234
K326
EPVVFEEKSHYKVDY
0 1
HIR (human) EPVVFEEKSHYKVDY K326
HIR (mouse) EPVVFEEkSHYKVDY K325-ub
HIR (rat) EPVVFEEKSHYKVDY K326
S356-p
SARELQEsKITVLPA
0 1
HIR (human) SARELQEsKITVLPA S356-p
HIR (mouse) SARELQESKITVLPA S355
HIR (rat) SARELQESKITVLPA S356
S421
IRMLEFGSHLDLERM
0 1
HIR (human) IRMLEFGSHLDLERM S421
HIR (mouse) IRMLEFGsHLDLERM S420-p
HIR (rat) IRMLEFGSHLDLERM S421
S443
NISYRRESAI_____
1 0
HIR (human) NISYRRESAI_____ S443
HIR (mouse) NISYRRESRI_____ S443
HIR (rat) NISYRREsAI_____ S444-p